Skip to content
10-K

Annual Report

CALITHERA BIOSCIENCES, INC.

0000950170-22-005227

← back to feed
Filed
Mar 31, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 25, 2022 78.72M sh
Cash And Equivalents FY 2021 · Dec 31, 2020 $107.15M
Current Liabilities FY 2021 · Dec 31, 2020 $18.4M
Total Liabilities FY 2021 · Dec 31, 2020 $23.22M
Current Assets FY 2021 · Dec 31, 2020 $118.7M
Total Assets FY 2021 · Dec 31, 2020 $125.59M
Capex FY 2021 · Dec 31, 2019 $7K
Operating Cash Flow FY 2021 · Dec 31, 2019 −$78.75M
Sga Expense FY 2021 · Dec 31, 2019 $16.61M
Net Income FY 2021 · Dec 31, 2019 −$89.86M
Operating Income FY 2021 · Dec 31, 2019 −$92.9M
Stockholders Equity FY 2021 · Dec 31, 2018 $126.71M